Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Core Scientific Q2 2024 Adj. EPS $(0.05) Misses $0.03 Estimate, Sales $141.102M Beat $128.574M Estimate

Author: Benzinga Newsdesk | August 07, 2024 06:07pm
Core Scientific (NASDAQ:CORZ) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $0.03 by 266.67 percent. The company reported quarterly sales of $141.102 million which beat the analyst consensus estimate of $128.574 million by 9.74 percent. This is a 11.18 percent increase over sales of $126.912 million the same period last year.

Posted In: CORZ

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist